Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats

Eur J Clin Invest. 2004 Apr;34(4):290-6. doi: 10.1111/j.1365-2362.2004.01336.x.

Abstract

Background/aims: Endothelin-1 (ET-1) may induce intrahepatic vasoconstriction and consequently increase portal pressure. Endothelin-1 has been shown to exert a direct vasoconstrictive effect on the collateral vessels in partially portal vein-ligated rats with a high degree of portal-systemic shunting. This study investigated the collateral vascular responses to ET-1, the receptors in mediation and the regulation of ET-1 action by nitric oxide and prostaglandin in cirrhotic rats with a relatively low degree of portal-systemic shunting.

Methods: The portal-systemic collaterals of common bile duct-ligated (BDL) cirrhotic rats were tested by in situ perfusion. The concentration-response curves of collaterals to graded concentrations of ET-1 (10(-10)-10(-7) m) with or without BQ-123 (ET(A) receptor antagonist, 2 x 10(-6) m), BQ-788 (ET(B) receptor antagonist, 10(-7) m) or both were recorded. In addition, the collateral responses to ET-1 with preincubation of N(omega)-nitro-L-arginine (NNA, 10(-4) M), indomethacin (INDO, 10(-5) M) or in combination were assessed.

Results: Endothelin-1 significantly increased the perfusion pressures of portal-systemic collaterals. The ET-1-induced constrictive effects were inhibited by BQ-123 or BQ-123 plus BQ-788 but not by BQ-788 alone. The inhibitory effect was greater in the combination group. Pretreatment of NNA or NNA plus INDO equivalently enhanced the response of ET-1 while pretreatment of INDO alone exerted no effect.

Conclusion: Endothelin-1 has a direct vasoconstrictive effect on the collaterals of BDL cirrhotic rats, mainly mediated by ET(A) receptor. Endogenous nitric oxide may play an important role in modulating the effects of ET-1 in the portal-systemic collaterals of BDL cirrhotic rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Antihypertensive Agents / pharmacology
  • Collateral Circulation / drug effects*
  • Common Bile Duct / physiopathology
  • Common Bile Duct / surgery
  • Endothelin Receptor Antagonists
  • Endothelin-1 / pharmacology*
  • Enzyme Inhibitors / pharmacology
  • Hypertension, Portal / physiopathology
  • Indomethacin / pharmacology
  • Ligation
  • Liver Cirrhosis, Experimental / metabolism
  • Liver Cirrhosis, Experimental / physiopathology*
  • Male
  • Nitric Oxide / antagonists & inhibitors
  • Nitroarginine / pharmacology
  • Oligopeptides / pharmacology
  • Peptides, Cyclic / pharmacology
  • Piperidines / pharmacology
  • Portal System / drug effects*
  • Prostaglandin Antagonists / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Vasoconstriction / drug effects
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Enzyme Inhibitors
  • Oligopeptides
  • Peptides, Cyclic
  • Piperidines
  • Prostaglandin Antagonists
  • Vasoconstrictor Agents
  • Nitroarginine
  • Nitric Oxide
  • BQ 788
  • cyclo(Trp-Asp-Pro-Val-Leu)
  • Indomethacin